• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖悖论与心力衰竭:十年证据的系统评价

The Obesity Paradox and Heart Failure: A Systematic Review of a Decade of Evidence.

作者信息

Oga Emmanuel Aja, Eseyin Olabimpe Ruth

机构信息

Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201, USA.

Department of Epidemiology, Harvard Chan School of Public Health, Boston, MA 02115, USA.

出版信息

J Obes. 2016;2016:9040248. doi: 10.1155/2016/9040248. Epub 2016 Jan 20.

DOI:10.1155/2016/9040248
PMID:26904277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4745816/
Abstract

There is scientific consensus that obesity increases the risk of cardiovascular diseases, including heart failure. However, among persons who already have heart failure, outcomes seem to be better in obese persons as compared with lean persons: this has been termed the obesity paradox, the mechanisms of which remain unclear. This study systematically reviewed the evidence of the relationship between heart failure mortality (and survival) and weight status. Search of the PubMed/MEDLINE and EMBASE databases was done according to the PRISMA protocol. The initial search identified 9879 potentially relevant papers, out of which ten studies met the inclusion criteria. One study was a randomized clinical trial and 9 were observational cohort studies: 6 prospective and 3 retrospective studies. All studies used the BMI, WC, or TSF as measure of body fatness and NYHA Classification of Heart Failure and had single outcomes, death, as study endpoint. All studies included in review were longitudinal studies. All ten studies reported improved outcomes for obese heart failure patients as compared with their normal weight counterparts; worse prognosis was demonstrated for extreme obesity (BMI > 40 kg/m(2)). The findings of this review will be of significance in informing the practice of asking obese persons with heart failure to lose weight. However, any such recommendation on weight loss must be consequent upon more conclusive evidence on the mechanisms of the obesity paradox in heart failure and exclusion of collider bias.

摘要

科学界已达成共识,即肥胖会增加包括心力衰竭在内的心血管疾病风险。然而,在已患有心力衰竭的人群中,肥胖者的预后似乎比瘦者更好:这一现象被称为肥胖悖论,其机制尚不清楚。本研究系统回顾了心力衰竭死亡率(及生存率)与体重状况之间关系的证据。按照PRISMA方案对PubMed/MEDLINE和EMBASE数据库进行了检索。初步检索确定了9879篇潜在相关论文,其中十项研究符合纳入标准。一项研究为随机临床试验,9项为观察性队列研究:6项前瞻性研究和3项回顾性研究。所有研究均使用体重指数(BMI)、腰围(WC)或三头肌皮褶厚度(TSF)作为身体脂肪的衡量指标,并采用纽约心脏病协会(NYHA)心力衰竭分级,且均以单一结局即死亡作为研究终点。纳入综述的所有研究均为纵向研究。所有十项研究均报告称,与正常体重的心力衰竭患者相比,肥胖患者的预后有所改善;极端肥胖(BMI>40 kg/m²)者则显示出更差的预后。本综述的研究结果对于指导心力衰竭肥胖患者减重的临床实践具有重要意义。然而,任何此类关于减重的建议都必须基于关于心力衰竭肥胖悖论机制的更确凿证据,并排除碰撞偏倚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9985/4745816/1510df0818d4/JOBE2016-9040248.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9985/4745816/1510df0818d4/JOBE2016-9040248.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9985/4745816/1510df0818d4/JOBE2016-9040248.001.jpg

相似文献

1
The Obesity Paradox and Heart Failure: A Systematic Review of a Decade of Evidence.肥胖悖论与心力衰竭:十年证据的系统评价
J Obes. 2016;2016:9040248. doi: 10.1155/2016/9040248. Epub 2016 Jan 20.
2
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Obesity as a risk factor for early-onset colorectal cancer: Evidence from a nationally representative database.肥胖作为早发性结直肠癌的一个风险因素:来自全国代表性数据库的证据。
World J Clin Oncol. 2025 Jul 24;16(7):108220. doi: 10.5306/wjco.v16.i7.108220.
2
Galectin-3 and Pentraxin-3 as Potential Biomarkers in Chronic Coronary Syndrome and Atrial Fibrillation: Insights from a 131-Patient Cohort.半乳糖凝集素-3和五聚素-3作为慢性冠状动脉综合征和心房颤动的潜在生物标志物:来自131例患者队列的见解
Int J Mol Sci. 2025 May 20;26(10):4909. doi: 10.3390/ijms26104909.
3
Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures.

本文引用的文献

1
Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.慢性心力衰竭患者体重指数与全因死亡率、心血管死亡率及住院率关系的Meta分析
Am J Cardiol. 2015 May 15;115(10):1428-34. doi: 10.1016/j.amjcard.2015.02.024. Epub 2015 Feb 18.
2
[Healthy obesity? Why the adiposity paradox is only seemingly paradox].[健康的肥胖?为何肥胖悖论只是看似自相矛盾]
Med Monatsschr Pharm. 2014 Feb;37(2):54-64; quiz 65-6.
3
Obesity paradox in end-stage kidney disease patients.
细化肥胖与心力衰竭之间的联系:来自胰高血糖素样肽-1受体激动剂试验及采用直接肥胖测量方法的研究的见解。
Cardiovasc Diabetol. 2025 May 22;24(1):224. doi: 10.1186/s12933-025-02778-6.
4
Treatment options for heart failure in individuals with overweight or obesity: a review.超重或肥胖个体心力衰竭的治疗选择:一项综述
Future Cardiol. 2025 Apr;21(5):315-329. doi: 10.1080/14796678.2025.2479378. Epub 2025 Mar 18.
5
No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study.射血分数降低的心力衰竭患者健康相关生活质量不存在肥胖悖论:VIDA多中心研究的见解
J Clin Med. 2024 Dec 12;13(24):7558. doi: 10.3390/jcm13247558.
6
Systematic preoperative approach for bariatric surgery, perioperative results, and economic impact.系统的减重手术术前方法、围手术期结果和经济影响。
Front Public Health. 2024 Oct 9;12:1439948. doi: 10.3389/fpubh.2024.1439948. eCollection 2024.
7
Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure.脂蛋白(a)作为预测缺血性心力衰竭不良结局的新型生物标志物。
Front Cardiovasc Med. 2024 Sep 5;11:1466146. doi: 10.3389/fcvm.2024.1466146. eCollection 2024.
8
Relationship between waist-to-height ratio and heart failure outcome: A single-centre prospective cohort study.腰高比与心力衰竭结局的关系:一项单中心前瞻性队列研究。
ESC Heart Fail. 2025 Feb;12(1):290-303. doi: 10.1002/ehf2.15029. Epub 2024 Sep 17.
9
The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions.慢性心力衰竭合并症的相互作用:挑战与解决方案。
Curr Cardiol Rev. 2024;20(3):13-29. doi: 10.2174/011573403X289572240206112303.
10
The Evolving Role of Vericiguat in Patients With Chronic Heart Failure.维立西呱在慢性心力衰竭患者中不断演变的作用
Cureus. 2023 Dec 1;15(12):e49782. doi: 10.7759/cureus.49782. eCollection 2023 Dec.
终末期肾病患者的肥胖悖论。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):415-25. doi: 10.1016/j.pcad.2013.10.005. Epub 2013 Oct 9.
4
Obesity and the obesity paradox in heart failure.肥胖与心力衰竭中的肥胖悖论。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):409-14. doi: 10.1016/j.pcad.2013.10.004. Epub 2013 Oct 5.
5
Fitness vs. fatness on all-cause mortality: a meta-analysis.体能与肥胖对全因死亡率的影响:一项荟萃分析。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):382-90. doi: 10.1016/j.pcad.2013.09.002. Epub 2013 Oct 11.
6
Body-mass index and mortality among adults with incident type 2 diabetes.成人 2 型糖尿病患者的体重指数与死亡率。
N Engl J Med. 2014 Jan 16;370(3):233-44. doi: 10.1056/NEJMoa1304501.
7
Obesity paradox in different populations: evidence and controversies.不同人群中的肥胖悖论:证据与争议
Future Cardiol. 2014 Jan;10(1):81-91. doi: 10.2217/fca.13.84.
8
Triceps skinfold as a prognostic predictor in outpatient heart failure.肱三头肌皮褶作为门诊心力衰竭的预后预测指标。
Arq Bras Cardiol. 2013 Nov;101(5):434-41. doi: 10.5935/abc.20130185. Epub 2013 Sep 13.
9
Overweight, mortality and survival.超重、死亡率与生存率。
Obesity (Silver Spring). 2013 Sep;21(9):1744-5. doi: 10.1002/oby.20588.
10
Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.心肺适能对心力衰竭患者肥胖悖论的影响。
Mayo Clin Proc. 2013 Mar;88(3):251-8. doi: 10.1016/j.mayocp.2012.11.020. Epub 2013 Feb 27.